longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Reviva Pharmaceuticals(RVPH.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Reviva Pharmaceuticals | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/14/2026 04:44
US
RVPH
-1.20%
Earnings Watch·05/14/2026 04:44
US
RVPH
-1.20%

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga_article·05/14/2026 01:06
US
RVPH
-1.20%
US
REPL
-6.19%
US
MXCT
-1.89%
benzinga_article·05/14/2026 01:06
US
RVPH
-1.20%
US
REPL
-6.19%
US
MXCT
-1.89%

Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights | RVPH Stock News

StockTitan·05/13/2026 20:35
US
RVPH
-1.20%
US
SBIO
-1.24%
US
PBE
+0.11%
StockTitan·05/13/2026 20:35
US
RVPH
-1.20%
US
SBIO
-1.24%
US
PBE
+0.11%

Reviva Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 EPS results.

benzinga_article·03/30/2026 22:45
US
PBE
+0.11%
US
IBB
+0.10%
US
LABD
+2.41%
benzinga_article·03/30/2026 22:45
US
PBE
+0.11%
US
IBB
+0.10%
US
LABD
+2.41%

Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights | RVPH Stock News

StockTitan·03/30/2026 10:05
US
LABU
-2.35%
US
RVPH
-1.20%
US
BIB
+0.05%
StockTitan·03/30/2026 10:05
US
LABU
-2.35%
US
RVPH
-1.20%
US
BIB
+0.05%

Reviva Pharmaceuticals | 8-K: FY2025 Revenue: USD 0

Earnings Watch·03/30/2026 18:13
US
RVPH
-1.20%
Earnings Watch·03/30/2026 18:13
US
RVPH
-1.20%

Reviva Pharmaceuticals | 10-K: FY2025 Revenue: USD 0

Earnings Watch·03/30/2026 18:09
US
RVPH
-1.20%
Earnings Watch·03/30/2026 18:09
US
RVPH
-1.20%
© 2026 Longbridge|Disclaimer

Event Tracking

May14
Reviva Pharmaceuticals released FY2026 Q1 earnings on May 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.46 (forecast USD -0.42)
03:00
Mar31
Reviva Pharmaceuticals released FY2025 Q4 earnings on March 30 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5696 (forecast USD -1.1666)
03:00
Reviva Pharmaceuticals released FY2025 earnings on March 30 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -5.4756 (forecast USD -6.8666)
03:00
Dec23
Reviva Pharmaceuticals Accepts FDA Recommendation for Second Phase 3 Clinical Trial of Brilaroxazine
14:47
Nov15
Reviva Pharmaceuticals Maintains Buy Rating, Target Price at $2.00
16:27
Nov14
Reviva Pharmaceuticals released FY2025 9 Months Earnings on November 13, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.3136
04:00

Schedules & Filings

Schedules
Filings
May13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -3.196 M, EPS -0.46

Mar30
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -3.368 M, EPS -0.567

Mar9
Reverse Stock Split(EST)

1-for-20 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INM
1.600
+135.05%
+0.919
AMPGZ
0.5800
+132.00%
+0.330
AMST
1.730
+120.07%
+0.944
CNEY
1.610
+119.77%
+0.877
AMPGR
0.5000
+102.02%
+0.253
NXXT
0.8201
+100.02%
+0.410
WNW
4.750
+97.10%
+2.340
GIPR
0.4290
+75.89%
+0.185
MTVA
1.880
+69.37%
+0.770
SVRN
8.200
+49.64%
+2.720
View More